/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR
DISSEMINATION IN THE UNITED
STATES./
TORONTO, Jan. 6, 2021 /CNW/ - MCI Onehealth Technologies
Inc. ("MCI Onehealth") (TSX: DRDR) announced today the successful
closing of its initial public offering (the "Offering") of an
aggregate of 6,000,000 Class A Subordinate Voting Shares (the
"Offered Shares") of MCI Onehealth at a price of $5.00 per Offered Share (the "Offering Price")
for aggregate gross proceeds of $30,000,000.
The Offered Shares will commence trading today on the Toronto
Stock Exchange under the symbol "DRDR".
The Offering was made through a syndicate of underwriters led by
Canaccord Genuity Corp., as lead underwriter and sole bookrunner,
and including Echelon Wealth Partners Inc., Stifel Nicolaus Canada
Inc., TD Securities Inc., Eight Capital, Haywood Securities Inc.
and Clarus Securities Inc. (collectively, the "Underwriters").
MCI Onehealth was represented by Fasken Martineau DuMoulin LLP
and the Underwriters were represented by Borden Ladner Gervais
LLP.
MCI Onehealth has granted the Underwriters an over-allotment
option (the "Over-Allotment Option"), exercisable in whole or in
part for a period of 30 days following the closing of the Offering,
to purchase up to an additional 900,000 Offered Shares at the
Offering Price for additional gross proceeds of approximately
$4,500,000 to MCI Onehealth, if the
Over-Allotment Option is exercised in full.
No securities regulatory authority has either approved or
disapproved the contents of this press release. This press release
does not constitute an offer to sell or the solicitation of an
offer to buy, nor shall there be any sale or any acceptance of an
offer to buy these securities in any jurisdiction in which such
offer, solicitation or sale would be unlawful.
The Offered Shares have not been and will not be registered
under the United States Securities Act of 1933 (the "U.S.
Securities Act"), as amended, or any state securities laws, and may
not be offered, sold or delivered, directly or indirectly, in
the United States or to, or for
the account or benefit of, "U.S. persons" (as defined in Regulation
S under the U.S. Securities Act). Accordingly, the Offered Shares
may not be offered or sold within the
United States unless registered under the U.S. Securities
Act and applicable state securities laws or pursuant to exemptions
from the registration requirements of the U.S. Securities Act and
applicable state securities laws.
About MCI Onehealth Technologies Inc.
MCI Onehealth is focused on empowering patients and doctors with
advanced technologies to increase access, improve quality, and
reduce the cost of healthcare. As one of Canada's leading primary care networks with 25
technology enabled clinics, MCI Onehealth serves over 850,000
patients annually and has been a part of the healthcare community
for over 30 years. Since the deployment of MCI/Connect, the
company's proprietary digital platform, MCI Onehealth continues to
develop an ecosystem of digital applications, which will target
modernizing and personalizing the primary care experience. MCI
Onehealth additionally offers an expanding suite of occupational
health service offerings that support a growing list of over 250
corporate customers. Driven by a proven management team of doctors
and experienced executives, MCI Onehealth is executing a strategy
focused on acquiring technology and health services that complement
its technology and data–focused roadmap. Additional information can
be found at www.mcionehealth.com.
Forward Looking Statements
This press release may contain forward–looking information
within the meaning of applicable securities legislation, which
reflects MCI Onehealth's current expectations regarding future
events. Forward–looking information is based on a number of
assumptions and is subject to a number of risks and uncertainties,
many of which are beyond MCI Onehealth's control, which could cause
actual results and events to differ materially from those that are
disclosed in or implied by such forward–looking information. Such
risks and uncertainties include, but are not limited to the ability
of MCI Onehealth to execute on its strategy and the factors
discussed under "Risk Factors" in the final prospectus of
MCI Onehealth dated December 29,
2020. MCI Onehealth does not undertake any obligation to
update such forward–looking information, whether as a result of new
information, future events or otherwise, except as expressly
required by applicable law.
SOURCE MCI OneHealth Technologies Inc.
